Sepsis affects approximately 30 million worldwide, meaning it is crucial that effective and affordable management techniques – that don’t facilitate the rise in antimicrobial resistance – are found. This article assesses the burden of sepsis on the US healthcare system and starts to assess the usefulness of pancreatic stone protein (PSP) as a promising biomarker in the early detection of the disease. Read more here.
Getz Healthcare is proud to be recognized as the leading distributor of medical equipment, devices and consumables, in Asia Pacific.
Our full-service distribution capabilities provide end-to-end representation of our business partners’ products, while delivering comprehensive service and solutions to our customers in all the countries we serve. Learn more
All product information listed on this site are for healthcare professionals only. Descriptions and specifications of the products listed on this site are provided by the manufacturer.